drugset / Trial / NCT02024269

Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration

NCT02024269

Withdrawn Bioheart, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This will be an open-label, non-randomized multi-center study of adipose stem cell (ASC) implantation. ASCs will be derived from the patient's adipose or fat. Liposuction using local anesthesia and syringe collection will be performed to collect the adipose tissue specimen for subsequent processing to isolate the stem cells. The cells will be delivered via needle injection into the eye.

Timeline

Start
2013-12
Primary completion
2016-12
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Intravitreal